SYDNEY, March 31 (RHC-Xinhua) -- An all-new generation of long- lasting drugs for melanoma may flow from a new discovery by an Australian researcher.
The University of Newcastle announced on Tuesday that Professor Xu Dong Zhang found that a protein known as RIP1, previously linked to natural cell death in the body, has a pro-survival function in melanoma cells.
